Resources - Volition

Together against canine cancer: an insight into our collabor…

Volition’s Non-Hodgkin Lymphoma Research

2024 Mid-Year Review with Cameron Reynolds, Group CEO of Vol…

Martin Faulkes retires as Executive Chairman of Volition

Nu.Q® Discover White Paper: The epigenetic keys to unlocking…

Scientific Advisory Board Update

Subscribe for Volition product updates.

Or, click here for Investor Updates and press releases

"*" indicates required fields

Receive product updates for:

Animal Health

Human Health

Name*

First Name Last Name

Company Name*

Your Email Address*

CAPTCHA

Meet Ben Berman

Meet Remi Rabeuf

Genomeweb to Host Volition Webinar on Neutrophils.

Early cancer detection by plasma CTCF transcription factor a…

Nu.Q® NETs: New sepsis study at Guy’s & St Thomas…

Meet Marielle Herzog, our R&D Director

Volition Business Review 2023

London Vet Show 2023: Volition Veterinary Highlights.

Learn about NETs, NETosis and Nu.Q^® NETs.

Volition’s collaboration with Professor Lea Payen and …

Scaling Up for Success: Volition Partners with IVD Research …

Celebrating International Day of Women and Girls in Science.

Meet Gaetan Michel

Volition Business Review 2022

Our Scientific Advisory Board meeting 2022

A spotlight on Volition’s Asia Strategy.

A spotlight on…Volition’s Commercialisation Stra…

A spotlight on… Volition’s U.S. Clinical Product…

Volition to Host Second Genomeweb Webinar.

Volition Opens New Innovation Hub.

Epigenetic cancer tests for both ends of the leash.

Meet Tom Butera

Meet Terry Kelly

Business Review 2021